01/06/2016
Julio Celis, Chairman of the Science Policy Committee of the European Academy of Cancer Sciences; Danish Cancer Society Research Center, Copenhagen. Associated Scientific Director of the Danish Cancer Society Research Center. He has been Chairman of the European Molecular Biology Laboratory (EMBL) Council (1997-1999), Vice President of the Human Proteome Organization (HUPO; 2002), Chair of the Initiative for Science in Europe (ISE; 2005-2007), President of the European Molecular Biology Conference (EMBC/EMBO; 2000-2003), Secretary General of the Federation of European Biochemical Societies (FEBS; 1999-2007), President of the European Life Sciences Forum (ELSF; 2001-2007), President of the European Association for Cancer Research (2012-2014), Chairman of the Policy Committee of the European CanCer Organisation (ECCO; 2008-2014), and Vice-President of the Alliance for Biomedical Research in Europe (2011-2014). He is currently Advisor to the Scientific Panel for Health in Horizon 2020 (2015-), member of the European Commission Research, Innovation and Science Experts (RISE) High-Level Advisory Board (2015-), Chairman of the Science Policy Committee of the EACS, and Editor-in-Chief of Molecular Oncology (2007-). Prof Celis has organized several international laboratory courses, Summer Schools, and Congresses and is generally recognized as one of the founding fathers of proteomics. He is member of the Royal Danish Academy of Sciences and Letters, the European Molecular Biology Organization (EMBO), the Academia Europaea, the European Academy of Cancer Sciences (EACS), and the Chilean Academy of Sciences.
01manuelheitor.mp4
La Academia Europaea, desafiando al futuro
01/06/2016
La carrera científica (los programas ICREA y Serra Hunter)
01/06/2016
Desarrollo de un centro de investigación de excelencia (CNIO) y su relación con el ciudadano
01/06/2016
Promoción y desarrollo de una política de ciencia de excelencia (la Institución CERCA)
01/06/2016
La European Science Foundation
01/06/2016
Dando forma a una política de investigación en cáncer en la UE: Hacia un instituto virtual europeo del cáncer
01/06/2016